- Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of WTBRAF/WTNRAS melanoma cells to vemurafenib
Mohammad Krayem et al, 2014, European Journal of Cancer CrossRef - Molecular Pathways: Adaptive Kinome Reprogramming in Response to Targeted Inhibition of the BRAF–MEK–ERK Pathway in Cancer
Gary L. Johnson et al, 2014, Clinical Cancer Research CrossRef - STAT3 Inhibitors in Cancer: A Comprehensive Update
Uddalak Bharadwaj et al, 2016, STAT Inhibitors in Cancer CrossRef - Mechanism-based cancer therapy: resistance to therapy, therapy for resistance
P Ramos et al, 2015, Oncogene CrossRef - Lentiginoses in polycythemia vera patient: Is there a role forJAK2 (V617F)mutation?
Tugba Kevser Uzuncakmak et al, 2015, JAK-STAT CrossRef